Key result
Lovastatin protects human endothelial cells from radiation-induced death without impairing DNA repair.
Why the study?
Does lovastatin protect primary human umbilical vein endothelial cells from ionizing radiation-induced cytotoxicity?
Population
Primary human umbilical vein endothelial cells (HUVEC) and human fibroblasts
Comparison
Lovastatin prior to ionizing radiation vs Ionizing radiation alone
Design
Preclinical
Authors
Loading...
May support endothelial radioprotection during radiotherapy; leaves open clinical translation and effects on tumor control.
Does lovastatin protect primary human umbilical vein endothelial cells from ionizing radiation-induced cytotoxicity?
Lovastatin protects human endothelial cells from radiation-induced cell death by modulating stress responses without impairing DNA double-strand break repair, suggesting potential utility in mitigating radiation therapy side effects.
Nübel et al. (2006) studied Ionizing radiation-induced endothelial cell damage. Lovastatin was evaluated on Ionizing radiation-induced cell death. Lovastatin protected primary human umbilical vein endothelial cells from ionizing radiation-induced cell death at a dose of 1 micromol/L without impairing DNA double-strand break repair.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: